Parkinson's Disease clinical trials in Pennsylvania
33 active Parkinson's Disease trials with a site in Pennsylvania. Describe your situation to see which ones look like a fit.
- Adaptive Neurostimulation to Restore Sleep in Parkinson's Disease (Aim 2)
- A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
- A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
- A Study of Buntanetap in Participants With PD
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Impact of a Biophoton Therapy on Patients With Brain Disorders
- Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.
- Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15
- CW2IP2: Imaging and Diagnostic Assessments
- PET Tau - Neurodegenerative Disease Imaging
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
- A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
- Parkinson's Foundation PD GENEration Genetic Registry
- Parkinson's Disease and Movement Disorders Clinical Database
- PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Abbott DBS Post-Market Study of Outcomes for Indications Over Time
- Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- UPenn Observational Research Repository on Neurodegenerative Disease
- Stimulating Specific Brain Areas (VOP/VIM) With Electricity to Improve Movement and Muscle Control
- Neurophysiology of the Basal Ganglia, Thalamus, and Cerebellum in Patients With Movement Disorders
- Using the EHR to Advance Genomic Medicine Across a Diverse Health System
- Voiceitt for People With Impairments in Speech
- Prescriptive Infusion Algorithm (PIA)
- Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
- Pilot Deprescribing of Antimuscarinic Overactive Bladder Medications in Parkinson Disease
- Gamification and Physical Activity in PD
- Study in Parkinson Disease of Exercise
- Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.